Echocardiographic assessment of cardiovascular involvements in children with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- Ghaffaripour H
Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective review.
primary studies published, non RCT
Details- 2024
- Guenther EL
Peri-operative and long-term outcomes of kidney transplantation in patients with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- O'Kelly JA
Improvement in Lung Clearance Index and Chest CT Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Study.
primary studies published, non RCT
Details- 2023
- McNally P
Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.
primary studies published, non RCT
Details- 2023
- Grancini V
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data.
primary studies published, non RCT
Details- 2023
- Granger E
Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.
primary studies published, non RCT
Details- 2023
- McElvaney OJ
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease.
primary studies published, non RCT
Details- 2023
- Siegel MJ
Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.
primary studies published, non RCT
Details- 2021
- Barreda CB
Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis.
primary studies published, non RCT
Details- 2022
- Berg P